Zobrazeno 1 - 10
of 46
pro vyhledávání: '"T A, Panafidina"'
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 6, Pp 678-688 (2024)
The term of “incomplete” systemic lupus erythematosus (iSLE) is used when patients have typical clinical and immunological signs of lupus without fulfilling the classification criteria for SLE. Autoantibodies appear in patients years before diagn
Externí odkaz:
https://doaj.org/article/7784fc51685842ab86feaa5202449588
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 100-105 (2023)
The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis.
Externí odkaz:
https://doaj.org/article/0c02e8fcf482449b86a55c10bf1303e0
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 3, Pp 347-352 (2022)
Objective – to identify obesity/overweight phenotypes in patients with systemic lupus erythematosus (SLE) based on the body mass index (BMI) and serum leptin levels assessment, and to clarify the relationship of these phenotypes with different meta
Externí odkaz:
https://doaj.org/article/4895db52dc874478a063c490832a6e03
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 3 (2023)
Objective – to identify different phenotypes of overweight in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) based on body mass index (BMI) and serum leptin levels, as well as to determine the frequencies of various met
Externí odkaz:
https://doaj.org/article/0a1978740dca4b5a88284bfe46ebfb51
Publikováno v:
Современная ревматология, Vol 15, Iss 6, Pp 61-66 (2021)
Objective: to study the frequency of hyperleptinemia in patients with systemic lupus erythematosus (SLE), its relationship with clinical and laboratory manifestations of the disease, drug therapy, and other metabolic disorders.Patients and methods. T
Externí odkaz:
https://doaj.org/article/5623051b13574be7a2b2a586e4b8ba91
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 2, Pp 119-128 (2021)
Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease of unknown etiology, characterized by overproduction of organ-nonspecific autoantibodies to various components of the cell nucleus and cytoplasm and the development of immune-infla
Externí odkaz:
https://doaj.org/article/31d451a4d21147cb9a0500aa733465ce
Autor:
N. L. Kozlovskaya, S. K. Solovyev, E. A. Aseeva, T. V. Popkova, T. A. Panafidina, E. L. Nasonov, A. M. Lila, A. A. Mesnyankina, N. Yu. Nikishina
Publikováno v:
Современная ревматология, Vol 15, Iss 1, Pp 9-14 (2021)
The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2
Externí odkaz:
https://doaj.org/article/ad037bdef3f84450bdb0d2dfadb97703
Autor:
N. L. Kozlovskaya, S. K. Solovyev, E. A. Aseeva, T. V. Popkova, T. A. Panafidina, E. L. Nasonov, A. M. Lila, A. A. Mesnyankina, N. Yu. Nikishina
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 7-15 (2020)
The paper presents the main provisions of the 2019 updated European League Against Rheumatism (EULAR)/European Renal Association (ERA) – European Dialysis and Transplant Association (EDTA) guidelines for the management of lupus nephritis. It discus
Externí odkaz:
https://doaj.org/article/282aaa188cb3413cbbfe9a1da968d5ed
Publikováno v:
Современная ревматология, Vol 14, Iss 1, Pp 20-25 (2020)
Objective: to determine body composition (BC) in women with systemic lupus erythematosus (SLE), by using bioimpedance analysis.Patients and methods. The investigation enrolled 12 women with a reliable diagnosis of SLE, who were followed up at the Cli
Externí odkaz:
https://doaj.org/article/75ee358716eb46c380e4979421cbf74b
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 5, Pp 496-510 (2019)
A diversity of the clinical manifestations of systemic lupus erythematosus (SLE) and its undulating course with alternating remissions and exacerbations make this disease one of the most difficult ones to diagnose, treat, and evaluate the efficiency
Externí odkaz:
https://doaj.org/article/a440292f952e4392bfa4eac6a26e471e